Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

52
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
52
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

29
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
29
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

28
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
28
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

34
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
34

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pre-hospital and emergency department point-of-care ultrasound in cardiovascular emergencies: a scoping review.

Cardiovascular diagnosis and therapy·2026
Same author

SpaceMed: Immersive interdisciplinary academic training for the future of human space exploration.

Experimental physiology·2026
Same author

Anatomical variations of the coeliac trunk: a scoping review of classification systems.

Irish journal of medical science·2026
Same author

Emphasizing the diagnostic and management challenge: Nodular sclerosis Hodgkin lymphoma with pericardial infiltration in an adolescent male - A case report.

Leukemia research reports·2026
Same author

Uncomplicated type B aortic dissection with high-risk features are complicated.

Asian cardiovascular & thoracic annals·2026
Same author

Network oscillatory dynamics accompany cerebral bioenergetic defence in hypoxia.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism·2026

Related Experiment Video

Updated: Sep 17, 2025

Novel and Innovative Hybrid Technique for Type A Aortic Dissection
06:26

Novel and Innovative Hybrid Technique for Type A Aortic Dissection

Published on: March 28, 2025

499

TEVAR Versus Optimal Medical Therapy for Uncomplicated Type B Aortic Dissection: A Systematic Review & Meta-analysis.

Matti Jubouri1, Abdelaziz O Surkhi2, Abdullah I Alsarayrah3

  • 1Hull York Medical School, University of York, York, UK.

Annals of Vascular Surgery
|June 29, 2025
PubMed
Summary

Thoracic endovascular aortic repair (TEVAR) shows improved survival rates for uncomplicated Type B aortic dissection (unTBAD) compared to optimal medical therapy (OMT) alone. Further research is needed to establish definitive guidelines for this patient group.

More Related Videos

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

11.8K
Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

1.8K

Related Experiment Videos

Last Updated: Sep 17, 2025

Novel and Innovative Hybrid Technique for Type A Aortic Dissection
06:26

Novel and Innovative Hybrid Technique for Type A Aortic Dissection

Published on: March 28, 2025

499
Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

11.8K
Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

1.8K

Area of Science:

  • Cardiovascular Surgery
  • Vascular Medicine
  • Medical Imaging

Background:

  • Uncomplicated Type B aortic dissection (unTBAD) management is debated.
  • Optimal medical therapy (OMT) and thoracic endovascular aortic repair (TEVAR) are primary treatment options.
  • Evaluating TEVAR's impact on mortality and complications is crucial.

Purpose of the Study:

  • To compare the long-term outcomes of TEVAR plus OMT versus OMT alone for unTBAD.
  • To assess TEVAR's effect on overall mortality and specific complications.
  • To analyze survival rates and aortic remodeling in unTBAD patients.

Main Methods:

  • Meta-analysis of studies comparing TEVAR and OMT for unTBAD.
  • Searches conducted on PubMed, Ovid, Scopus, and EMBASE.
  • Statistical analysis performed using Jamovi, adhering to PRISMA guidelines.

Main Results:

  • Analysis included 25,650 patients (4,609 TEVAR, 21,041 OMT).
  • No significant difference in 30-day mortality; TEVAR showed improved survival rates at 1, 2, and 3 years.
  • TEVAR group survival: 98% at baseline, 94% at 1 year, 83.7% at 2 years, 89.9% at 3 years.

Conclusions:

  • TEVAR may improve survival in unTBAD patients, though definitive evidence is pending.
  • Improved aortic remodeling observed post-TEVAR.
  • Randomized trials and high-risk feature identification are needed for guideline development.